Benedetta Sensini
Perugia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The Farnesoid X receptor-bile acid axis contributes to immune evasion in gastric cancer and its inhibition enhances efficacy of anti-PD-L1 therapy.
Journal: Biochemistry and biophysics reports
Published: May 11, 2026
Tumor-Derived LIF Promotes GDF15-Driven Cachexia and Adverse Outcomes in Gastric Cancer.
Journal: Cells
Published: December 29, 2025
LIFR antagonism reverses epithelial pro-CAF programs in pancreatic ductal adenocarcinoma.
Journal: Biochemical pharmacology
Published: December 01, 2025
Harnessing the Estradienone Scaffold to Develop Dual GPBAR1 and LIFR Modulators for Liver Fibrosis.
Journal: Journal of medicinal chemistry
Published: September 24, 2025
Pharmacological inhibition of LIF signaling reverses PD-L1-mediated immune suppression in gastric cancer.
Journal: Translational oncology
Published: August 22, 2025
Leukemia inhibitory factor promotes human cholangiopathies, and its inhibition improves cholestasis in Abcb4-/- mice.
Journal: Hepatology communications
Published: February 26, 2025
Congenital goiter in an alpaca (Vicugna pacos) fetus concomitant with brain pathology in the dam: composing the puzzle.
Journal: Veterinary research communications
Published: December 16, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026